MORRISVILLE, N.C. – February 14, 2023 – Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today announced the launch of its Glucose...
Feb 8-9, 2023 San Diego, CA Metabolon is excited to participate in the 8th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference being held in San Diego, CA. The conference will bring together individuals from academia and industry who will be...
Metabolomics, the study of small-molecule metabolites, is becoming increasingly important in understanding the mechanisms behind cellular activity and disease. Historically, metabolites have been either supplemented or eliminated from growth media and diets to...
Metabolon Target β-Hydroxybutyrate (BHB) Single Analyte Assay R Absolute Quantitation R Rigorous Quality Control R End-to-end Service Get a Quote About β-Hydroxybutyrate β-Hydroxybutyrate (BHB, 3-hydroxybutyrate) is an endogenous ketone body that accumulates during...
INFOGRAPHICS 5 Risks Researchers take by not Prioritizing Metabolomics in Drug Development Is your drug development program at risk? Find out how metabolomics can be fundamental to unlocking biological insights otherwise unseen, making it a crucial component of drug...
Recent Comments